Creative Planning Portfolio holdings
AUM
$117B
1-Year Return
13.67%
This Quarter Return
-1.13%
1 Year Return
+13.67%
3 Year Return
+45.97%
5 Year Return
+68.1%
10 Year Return
+115.56%
AUM
$103B
AUM Growth
+$1.81B
(+1.8%)
Cap. Flow
+$3.43B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
46.02%
Holding
3,690
New
506
Increased
1,981
Reduced
979
Closed
136
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
+$639M |
| 2 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$524M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$213M |
| 4 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$205M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$174M |
Top Sells
| 1 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$204M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$113M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$87.9M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$59.8M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$29.9M |
Sector Composition
| 1 | Technology | 7.11% |
| 2 | Financials | 3.31% |
| 3 | Consumer Discretionary | 2.07% |
| 4 | Healthcare | 1.66% |
| 5 | Communication Services | 1.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Douglas Elliman
DOUG
$230M
| $25.2K | ﹤0.01% |
15,079
+2,628
| +21% | +$4.39K |
|
|
EMX
3302
EMX Royalty
EMX
$443M
| $24.9K | ﹤0.01% |
14,367
-1,578
| -10% | -$2.73K |
|
3303
XPEL
XPEL
$991M
| $23.7K | ﹤0.01% |
593
-4,196
| -88% | -$168K |
|
3304
Ameris Bancorp
ABCB
$5.07B
| $23.5K | ﹤0.01% |
+375
| New | +$23.5K |
|
3305
Lightwave Logic
LWLG
$393M
| $23.2K | ﹤0.01% |
11,057
-10,549
| -49% | -$22.2K |
|
3306
Establishment Labs
ESTA
$1.1B
| $22.7K | ﹤0.01% |
+492
| New | +$22.7K |
|
|
NTST
3307
NETSTREIT Corp
NTST
$1.75B
| $22.6K | ﹤0.01% |
1,595
-11,717
| -88% | -$166K |
|
3308
Arq
ARQ
$297M
| $22.5K | ﹤0.01% |
+2,971
| New | +$22.5K |
|
|
RGLS
3309
DELISTED
Regulus Therapeutics
RGLS
| $22.3K | ﹤0.01% |
14,116
-2,350
| -14% | -$3.71K |
|
3310
1-800-Flowers.com
FLWS
$326M
| $22.2K | ﹤0.01% |
+2,719
| New | +$22.2K |
|
3311
Jasper Therapeutics
JSPR
$41.9M
| $22.1K | ﹤0.01% |
+1,032
| New | +$22.1K |
|
3312
Stratasys
SSYS
$835M
| $21.9K | ﹤0.01% |
+2,468
| New | +$21.9K |
|
3313
Atlanticus Holdings
ATLC
$1.02B
| $21.9K | ﹤0.01% |
+392
| New | +$21.9K |
|
3314
PRA Group
PRAA
$653M
| $21.8K | ﹤0.01% |
+1,045
| New | +$21.8K |
|
3315
Helios Technologies
HLIO
$1.82B
| $21.7K | ﹤0.01% |
+485
| New | +$21.7K |
|
|
NMG
3316
Nouveau Monde Graphite
NMG
$296M
| $21.6K | ﹤0.01% |
13,588
| – | – |
|
3317
Orion Group Holdings
ORN
$295M
| $21.3K | ﹤0.01% |
+2,910
| New | +$21.3K |
|
3318
Kopin
KOPN
$342M
| $21.1K | ﹤0.01% |
15,488
-3,230
| -17% | -$4.39K |
|
3319
G-III Apparel Group
GIII
$1.13B
| $20.6K | ﹤0.01% |
+631
| New | +$20.6K |
|
3320
Gold Royalty Corp
GROY
$613M
| $20.3K | ﹤0.01% |
16,738
| – | – |
|
|
FL
3321
DELISTED
Foot Locker
FL
| $20.2K | ﹤0.01% |
927
-12,896
| -93% | -$281K |
|
3322
Sangamo Therapeutics
SGMO
$161M
| $20.1K | ﹤0.01% |
19,664
+679
| +4% | +$693 |
|
3323
Kymera Therapeutics
KYMR
$3.11B
| $19.6K | ﹤0.01% |
+487
| New | +$19.6K |
|
|
PRSU
3324
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.02B
| $19.6K | ﹤0.01% |
+460
| New | +$19.6K |
|
3325
Cytosorbents Corp
CTSO
$59.3M
| $19.4K | ﹤0.01% |
21,295
| – | – |
|